NCT02432079

Brief Summary

The goal of this study is to obtain specimens and data from individuals and their families with heterotaxy and related congenital heart defects in order to clarify the molecular genetics of this disorder. The knowledge gained from the analysis of this information will provide the basis for future genetic counseling as well as contribute to knowledge about the biology of normal and abnormal development of left-right anatomic asymmetry.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
56mo left

Started Jul 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jul 2009Dec 2030

Study Start

First participant enrolled

July 1, 2009

Completed
5.8 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 1, 2015

Completed
15.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

June 26, 2025

Status Verified

June 1, 2025

Enrollment Period

21.4 years

First QC Date

April 28, 2015

Last Update Submit

June 23, 2025

Conditions

Keywords

Abnormalities, MultipleAspleniaBilary AtresiaBirth DefectCardiovascular AbnormalitiesCardiovascular DiseasesCongenital AbnormalitiesCongenital Heart DiseaseDextrocardia SyndromeDisturbed Internal Organ PositioningGeneticsGenetic TestingHeart Defects, CongenitalHeart DiseasesHeterotaxy syndromeIntestinal malrotationLateralityLeft Atrial IsomerismPediatricsPolyspleniaRight Atrial IsomerismSplenic DiseasesCiliaSitus inversusDextrocardia

Outcome Measures

Primary Outcomes (1)

  • Clarify Molecular Genetics of Heterotaxy and Related Congenital Heart Defects

    These results will provide important information on the causes, management, and prognosis of heterotaxy and related congenital heart defects. This will provide the basis for future genetic testing and genetic counseling as well as contribute to knowledge about the biology of normal and abnormal development of left-right asymmetry.

    8 years

Study Arms (1)

Heterotaxy and congenital heart defects

Patients and family members with heterotaxy and related congenital heart defects

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

children affected with heterotaxy syndrome and/or congenital heart defects and their relatives

You may qualify if:

  • Subjects with heterotaxy and related congenital heart defects
  • Family members of subjects with heterotaxy and related congenital heart defects

You may not qualify if:

  • Subjects without heterotaxy and related congenital heart defects
  • Family members of subjects without heterotaxy and related congenital heart defects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University School of Medicine

Indianapolis, Indiana, 46202, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Whole Blood, Tissue Sample, Cheek Swabs, Saliva

MeSH Terms

Conditions

Heterotaxy SyndromeHeart Defects, CongenitalAbnormalities, MultipleCongenital AbnormalitiesCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesVolvulus Of MidgutSplenic DiseasesSitus InversusDextrocardia

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Stephanie M. Ware, MD, PhD

    Indiana University School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lindsey R. Helvaty, BA, BS

CONTACT

Stephanie M. Ware, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics and Medical and Molecular Genetics

Study Record Dates

First Submitted

April 28, 2015

First Posted

May 1, 2015

Study Start

July 1, 2009

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

December 1, 2030

Last Updated

June 26, 2025

Record last verified: 2025-06

Locations